|
Name |
Heneicosane
|
Molecular Formula | C21H44 | |
IUPAC Name* |
henicosane
|
|
SMILES |
CCCCCCCCCCCCCCCCCCCCC
|
|
InChI |
InChI=1S/C21H44/c1-3-5-7-9-11-13-15-17-19-21-20-18-16-14-12-10-8-6-4-2/h3-21H2,1-2H3
|
|
InChIKey |
FNAZRRHPUDJQCJ-UHFFFAOYSA-N
|
|
Synonyms |
HENEICOSANE; n-Heneicosane; Henicosane; 629-94-7; Eicosane, methyl-; I93S5U5DMP; CH3-[CH2]19-CH3; UNII-I93S5U5DMP; henicosan; Henicosane #; EINECS 211-118-9; Heneicosane, 98%; MFCD00009346; AI3-36479; Heneicosane, analytical standard; DTXSID9047097; CHEBI:32931; HSDB 8351; LMFA11000572; ZINC62233929; AKOS015902468; HY-W089845; AS-56310; DB-054362; CS-0132444; FT-0632670; H0367; D90848; Q150955; FD8EC3D3-E6A2-47B6-9E26-13A115192857; (S)-(-)-2,2'-Bis(diphenylphosphino)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl (R)-H8-BINAP
|
|
CAS | 629-94-7 | |
PubChem CID | 12403 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 296.6 | ALogp: | 11.0 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 18 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 21 | QED Weighted: | 0.206 |
Caco-2 Permeability: | -5.047 | MDCK Permeability: | 0.00000579 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.18 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.029 | Plasma Protein Binding (PPB): | 98.38% |
Volume Distribution (VD): | 4.419 | Fu: | 1.25% |
CYP1A2-inhibitor: | 0.095 | CYP1A2-substrate: | 0.161 |
CYP2C19-inhibitor: | 0.228 | CYP2C19-substrate: | 0.061 |
CYP2C9-inhibitor: | 0.051 | CYP2C9-substrate: | 0.961 |
CYP2D6-inhibitor: | 0.208 | CYP2D6-substrate: | 0.035 |
CYP3A4-inhibitor: | 0.173 | CYP3A4-substrate: | 0.027 |
Clearance (CL): | 4.482 | Half-life (T1/2): | 0.027 |
hERG Blockers: | 0.327 | Human Hepatotoxicity (H-HT): | 0.006 |
Drug-inuced Liver Injury (DILI): | 0.355 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.024 | Maximum Recommended Daily Dose: | 0.036 |
Skin Sensitization: | 0.965 | Carcinogencity: | 0.025 |
Eye Corrosion: | 0.996 | Eye Irritation: | 0.931 |
Respiratory Toxicity: | 0.381 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000432 | 0.953 | D00AOJ | 0.778 | ||||
ENC000285 | 0.951 | D07ILQ | 0.551 | ||||
ENC000442 | 0.910 | D00FGR | 0.528 | ||||
ENC000428 | 0.902 | D0Z5SM | 0.494 | ||||
ENC000446 | 0.871 | D00STJ | 0.471 | ||||
ENC000400 | 0.852 | D05ATI | 0.421 | ||||
ENC000431 | 0.848 | D0O1PH | 0.411 | ||||
ENC000433 | 0.836 | D0T9TJ | 0.395 | ||||
ENC000761 | 0.812 | D00MLW | 0.368 | ||||
ENC000715 | 0.812 | D0Z1QC | 0.320 |